Toyobo Of Japan Licenses Dutch Firm Crucell's Antibody Technology To Expand CRO Business
This article was originally published in PharmAsia News
Executive Summary
Japanese textile maker Toyobo plans to expand its contract drug development business through subsidiary Toyobo Gene Analysis